These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2315261)

  • 1. Verapamil-induced inhibition of theophylline elimination in healthy humans.
    Nielsen-Kudsk JE; Buhl JS; Johannessen AC
    Pharmacol Toxicol; 1990 Feb; 66(2):101-3. PubMed ID: 2315261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of theophylline elimination in rabbits by verapamil.
    Nielsen-Kudsk JE
    Pharmacol Toxicol; 1989 Apr; 64(4):349-51. PubMed ID: 2748541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium channel blockers on theophylline disposition.
    Sirmans SM; Pieper JA; Lalonde RL; Smith DG; Self TH
    Clin Pharmacol Ther; 1988 Jul; 44(1):29-34. PubMed ID: 3391002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers.
    Gin AS; Stringer KA; Welage LS; Wilton JH; Matthews GE
    J Clin Pharmacol; 1989 Aug; 29(8):728-32. PubMed ID: 2778093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of verapamil on theophylline serum concentrations.
    Rindone JP; Zuniga R; Sock JA
    Drug Metabol Drug Interact; 1989; 7(2-3):143-7. PubMed ID: 2698316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of three different oral doses of verapamil on the disposition of theophylline.
    Stringer KA; Mallet J; Clarke M; Lindenfeld JA
    Eur J Clin Pharmacol; 1992; 43(1):35-8. PubMed ID: 1505606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of theophylline clearance by oral albuterol.
    Amitai Y; Glustein J; Godfrey S
    Chest; 1992 Sep; 102(3):786-9. PubMed ID: 1516404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline.
    Couet W; Ingrand I; Reigner B; Girault J; Bizouard J; Fourtillan JB
    Eur J Clin Pharmacol; 1989; 37(1):101-4. PubMed ID: 2591458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m).
    Streit M; Göggelmann C; Dehnert C; Burhenne J; Riedel KD; Menold E; Mikus G; Bärtsch P; Haefeli WE
    Eur J Clin Pharmacol; 2005 Mar; 61(1):39-46. PubMed ID: 15692829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of type II diabetes mellitus on theophylline elimination.
    Adithan C; Sriram G; Swaminathan RP; Krishnan M; Bapna JS; Chandrasekar S
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):258-60. PubMed ID: 2737793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of piroxicam on theophylline clearance in healthy volunteers.
    Maponga C; Barlow JC; Schentag JJ
    DICP; 1990 Feb; 24(2):123-6. PubMed ID: 2309506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rifampin on theophylline kinetics.
    Boyce EG; Dukes GE; Rollins DE; Sudds TW
    J Clin Pharmacol; 1986; 26(8):696-9. PubMed ID: 3793963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of theophylline elimination by diltiazem therapy.
    Nafziger AN; May JJ; Bertino JS
    J Clin Pharmacol; 1987 Nov; 27(11):862-5. PubMed ID: 3429693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of caffeine on the steady-state pharmacokinetics of theophylline.
    Jonkman JH; Sollie FA; Sauter R; Steinijans VW
    Clin Pharmacol Ther; 1991 Mar; 49(3):248-55. PubMed ID: 2007319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of theophylline elimination by erythromycin.
    Renton KW; Gray JD; Hung OR
    Clin Pharmacol Ther; 1981 Sep; 30(3):422-6. PubMed ID: 7273607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of ceftibuten to alter single dose theophylline clearance.
    Bachmann K; Schwartz J; Jauregui L; Martin M; Nunlee M
    J Clin Pharmacol; 1990 May; 30(5):444-8. PubMed ID: 2347955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
    Lacarelle B; Blin O; Audebert C; Auquier P; Karsenty H; Horriere F; Durand A
    Eur J Clin Pharmacol; 1994; 46(5):477-8. PubMed ID: 7957547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-verapamil interaction.
    Pedersen KE; Dorph-Pedersen A; Hvidt S; Klitgaard NA; Nielsen-Kudsk F
    Clin Pharmacol Ther; 1981 Sep; 30(3):311-6. PubMed ID: 7273594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.